The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15079025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. In a population-based sample (n = 6,852) with complete follow-up, APOE was weakly associated with myocardial infarction and not related with stroke. In the absence of epsilon4, the incidence of dementia would be 25.8% lower; in the absence of epsilon2/epsilon3, 2.8% higher. Risk estimates of dementia, specified for age, sex, and APOE, are provided for counseling. APOE is not strongly related to vascular diseases, but contributes substantially to dementia incidence.
Medical subject headings
- Apolipoproteins E
- Dementia
- Myocardial Infarction
- Stroke